Top

Published in:

01-01-2006 | Current Status

Chemoprevention of Colorectal Cancer

Authors: Ramu Raju, M.D., Marcia Cruz-Correa, M.D., Ph.D.

Published in: Diseases of the Colon & Rectum | Issue 1/2006

Abstract

Colorectal cancer is a major public health concern in all developed countries. Despite decades of advances in the treatment and prevention of colorectal cancer, it remains the second most common cause of cancer death. However, the optimal method for early detection remains unknown and patient compliance with screening recommendations remains poor. This has led to the development of complementary strategies, such as chemoprevention to reduce morbidity and mortality from colorectal cancer. Chemoprevention is defined as the use of specific pharmacologic or nutrient agents to prevent, reverse, or inhibit the process of carcinogenesis. This review was designed to discuss the most promising agents in colorectal chemoprevention.

Jemal, A, Murray, T, Samuels, A, et al. 2003Cancer statistics 2003CA Cancer J Clin53526PubMed

Fearon, ER, Vogelstein, B 1990A genetic model for colorectal tumorigenesisCell61759767PubMedCrossRef

Kelloff, GJ, Boone, CW, Crowell, JA, et al. 1996Risk biomarkers and current strategies for cancer. chemopreventionJ Cell Biochem Suppl25114PubMed

Atkin, WS, Morson, BC, Cuzick, J 1992Long-term risk of colorectal cancer after excision of rectosigmoid adenomasN Engl J Med326658662PubMedCrossRef

Winawer, SJ, Zauber, AG, Ho, MN, et al. 1993Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study WorkgroupN Engl J Med32919771981PubMedCrossRef

Ruffin, MT, Krishnan, K, Rock, CL, et al. 1997Suppression of human colorectal mucosal prostaglandins: determining the lowest effective doseJ Natl Cancer Inst8911521160PubMedCrossRef

Eberhart, CE, Coffey, RJ, Radhika, A, Giaardello, FM, Ferrenbach, S, DuBois, RN 1994Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomasGastroenterology10711831188PubMed

Sheng, H, Shao, J, Kirkland, SC, et al. 1991Inhibition of human colon cancer cell growth by selective inhibition of cyclo-oxygenase 2J Clin Invest9922542259

Shiff, SJ, Rigas, B 1999The role of cyclooxygenase inhibition in the antineoplastic effects of nonsteroidal anti-inflammatory drugsJ Exp Med190445450PubMedCrossRef

10.

Yamamoto, Y, Yin, MJ, Lin, KM, Gaynor, RB 1999Sulindac inhibits activation of the NF-kappaB pathwayJ Biol Chem2742730727314PubMed

11.

Elder, DJ, Halton, DE, Hague, A, Paraskeva, C 1997Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expressionClin Cancer Res216791683

12.

Josyln, G, Carlson, M, Thliveris, A, et al. 1991Identification of deletion mutations and three new genes at the familial polyposis locusCell66600613

13.

Waddell, WR, Loughry, RW 1983Sulindac for polyposis of the colonJ Surg Oncol248387PubMed

14.

Giardiello, FM, Hamilton, SR, Krush, AJ, et al. 1993Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposisN Engl J Med32813131316PubMedCrossRef

15.

Nugent, KP, Farmer, KCR, Spigelman, AD, et al. 1993Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposisBr J Surg8016181619PubMed

16.

Labayle, D, Fischer, D, Vielh, P, et al. 1991Sulindac causes regression of rectal polyps in familial adenomatous polyposisGastroenterology101635639PubMed

17.

Cruz-Correa, M, Hylind, LM, Romans, KE, et al. 2002Long-term treatment with sulindac in familial adenomatous polyposis: a prospective cohort studyGastroenterology122641645PubMed

18.

Steinbach, G, Lynch, PM, Phillips, RK, et al. 2000The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposisN Engl J Med34219461952PubMedCrossRef

19.

Thun, MJ, Namboodiri, MM, Heath, CW,Jr 1991Aspirin use and reduced risk of fatal colon cancerN Engl J Med32515931596PubMedCrossRef

20.

Giovannucci, E, Rimm, EB, Stampfer, MJ, Colditz, GA, Ascherio, A, Willet, AC 1994Aspirin use and the risk for colorectal cancer and adenoma in male health professionalsAnn Intern Med121241246PubMed

21.

Giovannucci, E, Egan, KM, Hunter, DJ, et al. 1995Aspirin and the risk of colorectal cancer in womenN Engl J Med333609614PubMedCrossRef

22.

Smalley, W, Ray, WA, Daugherty, J, et al. 1999Use of nonsteroidal anti-inflammatory drugs and incidence of colorectal cancerArch Intern Med159161166PubMedCrossRef

23.

Sandler, RS, Halabi, S, Baron, JA, et al. 2003A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancerN Engl J Med348883890PubMed

24.

Baron, JA, Cole, BF, Sandler, RS, et al. 2003A randomized trial of aspirin to prevent colorectal adenomasN Engl J Med348891899PubMedCrossRef

25.

Wargovich, MJ, Eng, VW, Newmark, HL, Bruce, WR 1983Calcium ameliorates the toxic effect of deoxycholic acid on colonic epitheliumCarcinogenesis412051207PubMed

26.

Ochsenkuhn, T, Bayerdorffer, E, Meining, A, et al. 1999Colonic mucosal proliferation is related to serum deoxycholic acid levelsCancer8516641669PubMed

27.

Earnest, DL, Holubec, H, Wali, RK, et al. 1994Chemoprevention of azoxymethane-induced colonic carcinogenesis by supplemental dietary ursodeoxycholic acidCancer Res5450715074PubMed

28.

Pardi, DS, Loftus, EV,Jr, Kremens, WR, Keach, J, Lindor, KD 2003Ursodeoxycholic acid as a chemopreventative agent in patients with ulcerative colitis and primary sclerosing cholangitisGastroenterology124889893PubMedCrossRef

29.

Rossouw, JE, Anderson, GL, Prentice, RL, et al. 2002Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trialJAMA288321333PubMed

30.

Anderson, GL, Limacher, M, Assaf, AR, et al. 2004Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trialJAMA2917011712

31.

Calle, EE, Miracle-McMahill, HL, Thun, MJ, Heath, CW,Jr 1995Estrogen replacement therapy and risk of fatal colon cancer in a prospective cohort of postmenopausal womenJ Natl Cancer Inst87517523PubMed

32.

Grodstein, F, Martinez, ME, Platz, EA, et al. 1998Postmenopausal hormone use and risk for colorectal cancer and adenomaAnn Intern Med128705712PubMed

33.

Grodstein, F, Newcomb, PA, Stamfer, MJ 1999Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysisAm J Med106574582PubMedCrossRef

34.

Saydah, SH, Platz, EA, Rifai, N, Pollak, MN, Brancati, FL, Helzsouer, KJ 2003Association of markers of insulin and glucose control with subsequent colorectal cancer riskCancer Epidemiol Biomarkers Prev12412418PubMed

35.

Witte, D, Chirala, M, Younes, A, Li, Y, Younes, M 2001Estrogen receptor beta is expressed in human colorectal adenocarcinomaHum Pathol32940944PubMedCrossRef

36.

Baron, JA, Beach, M, Mandel, JS, et al. 1999Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study GroupN Engl J Med340101107PubMed

37.

Lipkin, M, Newmark, H 1985Effect of added dietary calcium on colonic epithelial-cell proliferation in subjects at high risk for familial colonic cancerN Engl J Med31313811384PubMedCrossRef

38.

Kopp, CB, Kronberg, O, Giacosa, A, et al. 2000Calcium and fibre supplementation in prevention of colorectal adenoma recurrence: a randomized intervention trial. European Cancer Prevention Organization Study GroupLancet35613001306

39.

Garland, CF, Garland, FC, Gorham, ED 1999Calcium and vitamin D. Their potential roles in colon and breast cancer preventionAnn N Y Acad Sci889107119PubMed

40.

McCullough, ML, Robertson, AS, Rodriguez, C, et al. 2003Calcium, vitamin D, dairy products, and risk of colorectal cancer in the Cancer Prevention Study II Nutrition CohortCancer Causes Control14112PubMed

41.

Holt, PR, Arber, N, Halmos, B, et al. 2002Colonic epithelial cell proliferation decreases with increasing levels of serum 25-hydroxy vitamin DCancer Epidemiol Biomarkers Prev11113119PubMed

42.

Bemd, GJ, Chang, GT 2002Vitamin D and vitamin D analogs in cancer treatmentCurr Drug Targets38594PubMed

43.

Giovannucci, E, Stampfer, MJ, Colditz, GA, et al. 1993Folate, methionine, and alcohol intake and risk of colorectal adenomaJ Natl Cancer Inst85875884PubMed

44.

Choi, SW, Mason, JB 2000Folate and carcinogenesis: an integrated schemeJ Nutr130129132PubMed

45.

Surh, YJ, Ferguson, LR 2003Dietary and medicinal antimutagens and anticarcinogens: molecular mechanisms and chemopreventative potential-highlights of a symposiumMutat Res523–52418PubMed

46.

Biasco, G, Paganelli, GM, Brandi, G, et al. 1992Chemoprevention of colorectal cancer: role of antioxidant vitaminsEur J Cancer Prev18291

47.

Giovannucci, E, Stampfer, MJ, Colditz, GA, et al. 1998Multivitamin use, folate, and colon cancer in women in the Nurses' Health StudyAnn Intern Med129517524PubMed

48.

Malila, N, Virtamo, J, Virtanen, M, Albanes, D, Tangrea, JA, Hutunen, JK 1999The effect of alpha-tocopherol and beta-carotene supplementation on colorectal adenomas in middle-aged smokersCancer Epidemiol Biomarkers Prev8489493PubMed

49.

Hennekens, CH, Buring, JE, Manson, JE, et al. 1996Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular diseaseN Engl J Med33411451149PubMedCrossRef

50.

Albanes, N, Malila, N, Taylor, PR, et al. 2000Effects of α-tocopherol and β-carotene on colorectal cancer: results from a controlled trial (Finland)Cancer Causes Control11197203PubMedCrossRef

51.

Feng, Y, Finley, JW, Davis, CD, et al. 1999Dietary selenium reduces the formation of aberrant crypts in rats administered 3,2'-dimethyl-4-aminobiphenylToxicol Appl Pharmacol1573642PubMedCrossRef

52.

Rao, CV, Cooma, I, Rodriguez, JG, et al. 2000Chemoprevention of familial adenomatous polyposis development in the APCmin mouse model by 1,4-phenylene bis(methylene)slelenocyanateCarcinogenesis21617621PubMedCrossRef

53.

Seo, YR, Kelley, MR, Smith, ML 2002Selenomethionine regulation of p53 by a ref1-dependent redox mechanismProc Natl Acad Sci99548553

54.

Clark, LC, Coombs, GF,Jr, Turnbull, BW, et al. 1996Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skinJAMA27619571963PubMedCrossRef

55.

Fuchs, CS, Giovannucci, EL, Colditz, GA, et al. 1999Dietary fiber and the risk of colorectal cancer and adenoma in womenN Engl J Med340169172PubMedCrossRef

56.

Schatzkin, A, Lanza, E, Corle, D, et al. 2000Lack of effect of a low-fat, high fiber diet on the recurrence of colorectal adenomasN Engl J Med34211491155PubMedCrossRef

57.

Bingham, SA, Day, NE, Luben, R, et al. 2003Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition: an observational studyLancet36114961591PubMedCrossRef

Ferrandez, A, DiSario, JA 2003Colorectal cancer: screening and surveillance for high-risk individualsExpert Rev Anticancer Ther3851862PubMedCrossRef

Martinez, ME 2005Primary prevention of colorectal cancer: lifestyle, nutrition, exerciseRecent Results Cancer Res166177211PubMed

Jemal, A, Tiwari, RC, Murray, T, et al. 2004Cancer statistics, 2004CA Cancer J Clin54829PubMedCrossRef

Nie, L, Feng, W, Diaz, R, Gratton, MA, Doyle, KJ, Yamoah, EN 2005Functional consequences of polyamine synthesis inhibition by L-alpha-difluoromethylornithine (DFMO): cellular mechanisms for DFMO-mediated ototoxicityJ Biol Chem2801509715102PubMedCrossRef

Bresalier, RS, Sandler, RS, Quan, H, et al. 2005Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trialN Engl J Med35210921102PubMedCrossRef

Solomon, SD, McMurray, JJ, Pfeffer, MA, et al. 2005Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma preventionN Engl J Med35210711080PubMed

Heiskanen, I, Jarvinen, HJ 1997Fate of the rectal stump after colectomy and ileorectal anastomosis for familial adenomatous polyposisInt J Colorectal Dis12913PubMedCrossRef

Steinbach, G, Lynch, PM, Phillips, RK, et al. 2000The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposisN Engl J Med34219461952PubMedCrossRef

Giardiello, FM, Hamilton, SR, Krush, AJ, et al. 1993Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposisN Engl J Med32813131316PubMedCrossRef

10.

Tonelli, F, Valanzano, R, Messerini, L, Ficari, F 2000Long-term treatment with sulindac in familial adenomatous polyposis: is there an actual efficacy in prevention of rectal cancer?J Surg Oncol741520PubMedCrossRef

11.

Cruz-Correa, M, Hylind, LM, Romans, KE, Booker, SV, Giardiello, FM 2002Long-term treatment with sulindac in familial adenomatous polyposis: a prospective cohort studyGastroenterology122641645PubMed

12.

Davidson, MH, Toth, PP 2004Comparative effects of lipid-lowering therapiesProg Cardiovasc Dis4773104PubMedCrossRef

Title: Chemoprevention of Colorectal Cancer
Authors: Ramu Raju, M.D.
Marcia Cruz-Correa, M.D., Ph.D.
Publication date: 01-01-2006
Publisher: Springer-Verlag
Published in: Diseases of the Colon & Rectum / Issue 1/2006
Print ISSN: 0012-3706
Electronic ISSN: 1530-0358
DOI: https://doi.org/10.1007/s10350-005-0170-1

At a glance: The STEP trials

Springer Medicine

Chemoprevention of Colorectal Cancer

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2006

Outcomes for Abdominoperineal Resections Are Not Worse Than Those of Anterior Resections

Metastatic Cutaneous Crohn's Disease of the Nipple: Report of a Case

Disseminated Intravascular Coagulation Associated With Systemic Cytomegalovirus Infection During Cyclosporine Therapy for Ulcerative Colitis: Report of a Case

Surveillance Colonoscopy in Individuals at Risk for Hereditary Nonpolyposis Colorectal Cancer: An Evidence-Based Review

Residency Programs in Colon and Rectal Surgery

Morphologic Alterations Associated With Mechanical Bowel Preparation Before Elective Colorectal Surgery: A Randomized Trial